Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenus
498,691
508,643
461,510
410,502
363,780
305,073
Croissance des revenus (H/H)
2%
10%
12%
13%
19%
1%
Coût des ventes
235,451
236,665
219,013
194,419
173,195
150,770
Bénéfice brut
263,240
271,978
242,497
216,083
190,585
154,303
Vente, Général et Administration
156,350
150,848
133,798
112,371
94,235
82,621
Recherche et développement
29,419
31,455
31,402
31,060
26,784
22,517
Frais d'exploitation
187,202
181,628
162,442
142,089
121,634
104,441
Autres revenus (charges) non opérationnels
--
-837
-662
-175
121
131
Bénéfice avant impôts
70,896
79,221
74,600
68,713
64,346
46,251
Charge d'impôt sur le revenu
24,380
25,645
24,826
22,988
20,274
14,385
Bénéfice net
46,686
53,669
49,639
45,784
44,093
31,905
Croissance du bénéfice net
-13%
8%
8%
4%
38%
-9%
Actions en circulation (diluées)
623.36
623.53
626.42
627.96
628.42
627.76
Variation des actions (H-H)
0%
0%
0%
0%
0%
0%
EPS (dilué)
74.88
86.07
79.24
72.91
70.16
50.82
Croissance du EPS
-13%
9%
9%
4%
38%
-9%
Flux de trésorerie libre
23,897
38,286
13,714
26,331
26,705
31,079
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
52.78%
53.47%
52.54%
52.63%
52.39%
50.57%
Marge opérationnelle
15.24%
17.76%
17.34%
18.02%
18.95%
16.34%
Marge bénéficiaire
9.36%
10.55%
10.75%
11.15%
12.12%
10.45%
Marge du flux de trésorerie libre
4.79%
7.52%
2.97%
6.41%
7.34%
10.18%
EBITDA
118,712
129,383
115,943
105,801
96,382
75,278
Marge EBITDA
23.8%
25.43%
25.12%
25.77%
26.49%
24.67%
D&A pour le résultat opérationnel
42,674
39,033
35,888
31,807
27,431
25,416
EBIT
76,038
90,350
80,055
73,994
68,951
49,862
Marge EBIT
15.24%
17.76%
17.34%
18.02%
18.95%
16.34%
Taux d'imposition effectif
34.38%
32.37%
33.27%
33.45%
31.5%
31.1%
Statistiques clés
Clôture préc.
$9.88
Prix d'ouverture
$9.88
Plage de la journée
$9.88 - $9.88
Plage de 52 semaines
$9.33 - $20.4
Volume
100
Volume moyen
1.2K
BPA (TTM)
0.47
Rendement en dividend
--
Capitalisation boursière
$6.1B
Qu’est-ce que Sysmex Corp. ?
Sysmex Corp. engages in the healthcare business. The company is headquartered in Kobe, Hyogo-Ken and currently employs 10,533 full-time employees. The firm conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.